An Unusual Adrenal Metastasis Secondary to Hürthle Cell Carcinoma of the Thyroid

Clinical Nuclear Medicine

Volumn 21, Issue 4, 1996, Pages 312-315

  Orsolon, Piergiuseppe ^a   Bagni, Bruno ^a   Geatti, Onelio ^a   Guerra, Ugo Paolo ^a  

^a Ospedale Civile   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADRENAL METASTASIS; ADRENAL SCINTISCANNING; AGED; ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CASE REPORT; FEMALE; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; THYROID CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROID SCINTISCANNING;

ADENOCARCINOMA; ADRENAL GLAND NEOPLASMS; AGED; BONE NEOPLASMS; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; THYROID NEOPLASMS;

EID: 0029987194     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199604000-00011     Document Type: Article

References (16)

1. Cooper DS, Schneyer CR: Follicular and Hurthle cell carcinoma of the thyroid. Endocrinol Metab Clin North Am 19: 577, 1990.
2. Collins SL: Etiopathogenesis of thyroid cancer. In Falk S (ed): Thyroid Disease. New York, Raven Press, 1990, pp 401-471.
3. Akslen LA, Thoresen SO, Glattre E, Haldorsen T, Schoultz M: Mortality of patients with differentiated thyroid carcinoma in Norway. The influence of sex, age, tumor stage, histologic type and residence at the time of diagnosis. Tidsskr Nor Laegeforen 109:1765, 1989.
4. Beirwaltes WH, Nishiyama RH, Thompson NW, Copp JE, Kubo A: Survival time and "care" in papillary and follicular thyroid carcinoma with distant metastases: Statistics following University of Michigan therapy. J Nucl Med 23:561, 1982.
5. Brown AB, Greening WP, Mc Cready VR, Shaw HJ, Harmen CL: Radioiodine treatment of metastatic thyroid carcinoma: The Royal Marsden Hospital experience. Br J Radiol 57:323, 1984.
6. Casara D, Rubello D, Saladini G, et al: Different features of pulmonary metastases in differentiated thyroid cancer: Natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34:1626, 1993.
7. Freitas JE, Gross MD, Ripleys S, Shapiro B: Radionuclide diagnosis and therapy of thyroid cancer: Current status report. Semin Nucl Med 15:106, 1985.
8. Justin EP, Seabold JE, Robinson RA, et al: Insular carcinoma: A distinct thyroid carcinoma with associated iodine-131 localization. J Nucl Med 32:1358, 1991.
9. Maheshwari YK, Strattor Hill C, Haynie TP, Hickey RC, Samaan NA: 131-I therapy in differentiated thyroid carcinoma: M.D. Anderson Hospital experience. Cancer 47:664, 1981.
10. Pacini F, Lippi F, Formica N, et al: Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 28:1888, 1987.
11. Schlumberger M, Tubiana M, De-Voltaire F, et al: Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 63:960, 1986.
12. Strong EW: Evaluation and surgical treatment of papillary and follicular carcinoma. In Falk S (ed): Thyroid disease. New York, Raven Press, 1990, pp 485-499.
13. Thomas RD, Batty VB: Metastatic malignant struma ovarii: Two case reports. Clin Nucl Med 17:577, 1992.
14. Maxon HR, Smith HS: Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 19:685, 1990.
15. Wu S-Y, Brown T, Milne N, et al: Iodine-131 total body scan extrathyroidal uptake of radioiodine. Semin Nucl Med 16:82, 1986.
16. Manier S, Nostrand D, Atkins F, Wu S-Y: Iodine-131 neck and chest scintigraphy. In Nostrand D, Baum S (eds): Atlas of Nuclear Medicine. Philadelphia, JB Lippincott Company, 1988, pp 144-149.